期刊
DRUG DESIGN DEVELOPMENT AND THERAPY
卷 15, 期 -, 页码 111-124出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S286315
关键词
chronic obstructive pulmonary disease; drugs; clinical trial; complications; pharmaceutical care
资金
- Zhejiang Provincial Natural Science Foundation of China [LYY19H280006]
- National Natural Science Foundation of China [81503129]
- Zhejiang Provincial Science Technology Projects of Traditional Chinese Medicine [2021ZB174]
- Clinical Research Projects of Zhejiang Medical Association [2019ZYC-A85]
COPD, as the fourth leading cause of death globally, significantly impacts quality of life. Drug therapy and pharmaceutical care play a vital role in COPD management, with new drug research and pharmaceutical care being important for improving quality of life for COPD patients.
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death across the globe. Its repeated exacerbation will seriously worsen the quality of life, aggravate the patients' symptoms, and bring a heavy burden on the patients and the society. Understanding the current status of drug therapy and the role of pharmaceutical care is essential for the management of COPD. In addition to the drugs already on the market, recent clinical trials also show that emerging novel drugs for treating COPD are being developed to prevent the symptoms, reduce the frequency of acute exacerbation, and improve the quality of life. Recent progress in new drug research should lead to novel treatment options for COPD patients in future clinical practice. The pharmaceutical care has shown significantly favourable impacts on addressing drug-related problems, supporting its vital role in the management of COPD, especially when there are a wide range of therapeutic agents. This review not only provides an overview of current treatment strategies but also further underlines the importance of new drug development and pharmaceutical care for patients with COPD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据